Get the Stockscreener App
11.34
0.00%
0.00
After Hours:
11.34
Embecta Corp stock is traded at $11.34, with a volume of 444.43K.
It is up +0.00% in the last 24 hours and down -16.80% over the past month.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
See More
Previous Close:
$11.34
Open:
$11.26
24h Volume:
444.43K
Relative Volume:
0.82
Market Cap:
$691.80M
Revenue:
$1.12B
Net Income/Loss:
$55.30M
P/E Ratio:
11.94
EPS:
0.95
Net Cash Flow:
$-30.30M
1W Performance:
-5.58%
1M Performance:
-16.80%
6M Performance:
-16.31%
1Y Performance:
+10.74%
1-Day Range:
$11.02
$11.39
1-Week Range:
$11.02
$12.58
52-Week Range:
$10.00
$21.48
Embecta Corp Stock (EMBC) Company Profile
Name
Embecta Corp
Sector
Industry
Phone
(862) 401-0000
Address
1209 ORANGE STREET, WILMINGTON
Compare EMBC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EMBC
Embecta Corp
|
11.34 | 691.80M | 1.12B | 55.30M | -30.30M | 0.95 |
|
ISRG
Intuitive Surgical Inc
|
482.74 | 175.60B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
198.71 | 59.07B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
92.54 | 44.80B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
212.91 | 31.51B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
79.51 | 15.75B | 3.90B | 392.30M | 288.10M | 1.95 |
Embecta Corp Stock (EMBC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-25 | Initiated | Mizuho | Neutral |
| Dec-02-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Nov-27-24 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-20-23 | Initiated | Wolfe Research | Peer Perform |
| Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Sep-08-22 | Initiated | BTIG Research | Neutral |
| Aug-01-22 | Initiated | Morgan Stanley | Equal-Weight |
| Jun-21-22 | Initiated | BofA Securities | Underperform |
View All
Embecta Corp Stock (EMBC) Latest News
Mizuho Initiates Coverage of Embecta (EMBC) with Neutral Recommendation - Nasdaq
Mizuho Initiates Embecta at Neutral With $15 Price Target - marketscreener.com
Mizuho sets Embecta stock with Neutral rating, $15 price target By Investing.com - Investing.com Canada
Mizuho sets Embecta stock with Neutral rating, $15 price target - Investing.com
Embecta Corporation: Hold Rating Amid Market Shifts and Strategic Uncertainties - TipRanks
(EMBC) Trading Advice - news.stocktradersdaily.com
Embecta shares study highlighting need for training, standardization in insulin delivery - Drug Delivery Business
Mayo Clinic Proceedings Publishes New Global Insulin Injection Recommendations - GlobeNewswire
Embecta Flat on Publication of Diabetes Education Piece - Baystreet.ca
Major Breakthrough: First Global Insulin Injection Guidelines in 10 Years Released by International Experts - Stock Titan
Embecta announces new publication in Mayo Clinic Proceedings on FITTER - TipRanks
Are Investors Undervaluing Embecta Corp. (NASDAQ:EMBC) By 49%? - Yahoo Finance
embecta recognized as Healthcare Technology Company of the Year - The Healthcare Technology Report.
When the Price of (EMBC) Talks, People Listen - news.stocktradersdaily.com
Bank of New York Mellon Corp Purchases 4,769 Shares of Embecta Corp. (NASDAQ:EMBC) - Defense World
Analyzing Embecta (NASDAQ:EMBC) and Lucid Diagnostics (NASDAQ:LUCD) - Defense World
Oppenheimer Asset Management Inc. Takes $209,000 Position in Embecta Corp. (NASDAQ:EMBC) - Defense World
Embecta Insider Ups Holding By 20% During Year - Yahoo
Embecta corp. director Morris Mayo sells shares worth $50,782 - MSN
Embecta: Weak Outlook But Mouth-Watering Valuation Skew Risk-Reward In Favour - Seeking Alpha
Embecta Stock: Weak Outlook But Mouth-Watering Valuation Skew Risk-Reward In Favour - Seeking Alpha
Director Makes Bold Move with Major Stock Purchase in Embecta Corporation - TipRanks
Embecta corp. director Melcher buys $177,646 in stock By Investing.com - Investing.com Canada
Embecta corp. director Melcher buys $177,646 in stock - Investing.com India
Where are the Opportunities in (EMBC) - news.stocktradersdaily.com
New York State Teachers Retirement System Has $1.55 Million Position in Embecta Corp. (NASDAQ:EMBC) - Defense World
Embecta Corp. (NASDAQ:EMBC) Short Interest Update - Defense World
Embecta Corp. (EMBC): Among Last Week’s Worst Dividend Stocks - Insider Monkey
These Were Last Week’s 10 Worst Dividend Stocks - Insider Monkey
embecta to Participate at the J.P. Morgan Global Leveraged Finance Conference - GlobeNewswire
MDT: 3 Healthcare IT Stocks Revolutionizing Patient Care - StockNews.com
Exclusive: Embecta's Strategic Financial Roadmap Unveiled at JP Morgan Conference - StockTitan
embecta to Participate at the J.P. Morgan Global Leveraged Finance Conference - GlobeNewswire Inc.
Embecta Corp. (NASDAQ:EMBC) Sees Significant Decline in Short Interest - MarketBeat
Embecta Corp. (NASDAQ:EMBC) Shares Sold by Savant Capital LLC - Defense World
Embecta (NASDAQ:EMBC) Stock Price Down 5.7% After Insider Selling - MarketBeat
Senior Manager, Indirect Sourcing (hybrid) - Built In
Milton Mayo Morris Sells 3,100 Shares of Embecta Corp. (NASDAQ:EMBC) Stock - MarketBeat
Yacktman Asset Management LP Reduces Stock Position in Embecta Corp. (NASDAQ:EMBC) - MarketBeat
Embecta corp. director Morris Mayo sells shares worth $50,782 By Investing.com - Investing.com Nigeria
Embecta Corp. Shareholders Elect Directors, Ratify Auditor - MSN
Embecta Corp. Shareholders Elect Directors, Ratify Auditor By Investing.com - Investing.com South Africa
Diabetes care company Embecta finds perfect shipping partner in UPS - UPS
Embecta (NASDAQ:EMBC) Shares Gap DownWhat's Next? - MarketBeat
Embecta Corp. Announces Quarterly Dividend of $0.15 (NASDAQ:EMBC) - MarketBeat
Embecta Corp Stock (EMBC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
3.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):